Circulating levels of hormones, lipids, and immune mediators in posttraumatic stress disorder - a three-month follow-up study

Frontiers in Psychiatry

Volumn 6, Issue MAR, 2015, Pages

  Jergović, Mladen ^a,d   Bendelja, Krešo ^a   Mlakar, Ana Savić ^a   Vojvoda, Valerija ^a   Aberle, Neda ^b   Jovanovic, Tanja ^c   Rabatić, Sabina ^d   Sabioncello, Ante ^d   Vidović, Andelko ^e  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

^c EMORY UNIVERSITY   (United States)

^d INSTITUTE OF IMMUNOLOGY   (Croatia)

^e University of Zagreb   (Croatia)

Author keywords

Biological markers; Cell adhesion molecules; Cholesterol; Cytokines; Leptin; Nerve growth factor; Posttraumatic stress disorder; Veterans

Indexed keywords

ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CD31 ANTIGEN; CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MOOD STABILIZER; NARCOTIC ANALGESIC AGENT; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PRASTERONE SULFATE; PROLACTIN; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANALYSIS OF COVARIANCE; ANALYSIS OF VARIANCE; ARTICLE; ASTHMA; BECK DEPRESSION INVENTORY; BLOOD PRESSURE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHRONIC PANCREATITIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFECTION; INFLAMMATION; LIMIT OF DETECTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PSORIASIS; PSYCHOMETRY; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATE TRAIT ANXIETY INVENTORY; TRIACYLGLYCEROL BLOOD LEVEL; ULCERATIVE COLITIS;

EID: 84927169281     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00049     Document Type: Article

References (100)

1. Ahmadi, N., Arora, R., Vaidya, N., Yehuda, R., and Ebrahimi, R. (2013). Post-traumatic stress disorder is associated with increased incidence of insulin resistance and metabolic syndrome. J. Am. Coll. Cardiol. 61, E1347. doi:10.1016/S0735-1097(13)61347-9.
2. Altman, D. G. (1991). Practical statistics for medical research. London: Chapman & Hall Available at: http://books.google.hr/books/about/Practical_statistics_for_medical_researc.html?id=vwalRnRxWQC&pgis=1 [Accessed December 16, 2014].
3. American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders, fifth edition. Arlington, VA: American Psychiatric Association doi:10.1176/appi.books.9780890425596.744053.
4. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders, revised third edition. Washington, DC: American Psychiatric Association.
5. Babic, R., Maslov, B., Babic, D., and Vasilj, I. (2013). The prevalence of metabolic syndrome in patient with posttraumatic stress disorder. Psychiatr. Danub. 25 Suppl 1, 45-50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23806967 [Accessed January 3, 2015].
6. Baker, D. G., Nievergelt, C. M., and O'Connor, D. T. (2012). Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 62, 663-73. doi:10.1016/j.neuropharm.2011.02.027.
7. Bartlett, J. W., and Frost, C. (2008). Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables. Ultrasound Obstet. Gynecol. 31, 466-75. doi:10.1002/uog.5256.
8. Bartoli, F., Carrà, G., Crocamo, C., Carretta, D., and Clerici, M. (2013). Metabolic syndrome in people suffering from posttraumatic stress disorder: a systematic review and meta analysis. Metab. Syndr. Relat. Disord. 11, 301-8. doi:10.1089/met.2013.0010.
9. Beck, A. T., Steer, R. a., and Carbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin. Psychol. Rev. 8, 77-100. doi:10.1016/0272-7358(88)90050-5.
10. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289-300. doi:10.2307/2346101.
11. Bjørnerem, A., Straume, B., Oian, P., and Berntsen, G. K. R. (2006). Seasonal variation of estradiol, follicle stimulating hormone, and dehydroepiandrosterone sulfate in women and men. J. Clin. Endocrinol. Metab. 91, 3798-802. doi:10.1210/jc.2006-0866.
12. Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., and Keane, T. M. (1995). The development of a clinician-administered PTSD scale. J. Trauma. Stress 8, 75-90. doi:10.1007/BF02105408.
13. Boscarino, J. A. (2004). Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann. N. Y. Acad. Sci. 1032, 141-53. doi:10.1196/annals.1314.011.
14. Boscarino, J. A., Forsberg, C. W., and Goldberg, J. (2010). A twin study of the association between PTSD symptoms and rheumatoid arthritis. Psychosom. Med. 72, 481-6. doi:10.1097/PSY.0b013e3181d9a80c.
15. Bremner, D., Vermetten, E., and Kelley, M. E. (2007). Cortisol, dehydroepiandrosterone, and estradiol measured over 24 hours in women with childhood sexual abuse-related posttraumatic stress disorder. J. Nerv. Ment. Dis. 195, 919-27. doi:10.1097/NMD.0b013e3181594ca0.
16. Butterfield, M. I., Stechuchak, K. M., Connor, K. M., Davidson, J. R. T., Wang, C., MacKuen, C. L., Pearlstein, A. M., and Marx, C. E. (2005). Neuroactive steroids and suicidality in posttraumatic stress disorder. Am. J. Psychiatry 162, 380-2. doi:10.1176/appi.ajp.162.2.380.
17. Cattozzo, G., Albeni, C., Calonaci, A., and De Luca, G. (2011). Evaluation of the analytical performance of the Beckman Coulter AU680 automated analytical system based on quality specifications for allowable performance derived from biological variation. Clin. Chem. Lab. Med. 49, 1563-7. doi:10.1515/CCLM.2011.629.
18. Cirulli, F., and Alleva, E. (2009). The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front. Neuroendocrinol. 30, 379-95. doi:10.1016/j.yfrne.2009.05.002.
19. Davis, L. L., Clark, D. M., Kramer, G. L., Moeller, F. G., and Petty, F. (1999). D fenfluramine challenge in posttraumatic stress disorder. Biol. Psychiatry 45, 928-30. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10202582 [Accessed January 6, 2015].
20. Dell'Osso, L., Carmassi, C., Del Debbio, A., Dell'Osso, M. C., Bianchi, C., da Pozzo, E., Origlia, N., Domenici, L., Massimetti, G., Marazziti, D., et al. (2009). Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog. Neuro-Psychopharmacology Biol. Psychiatry 33, 899-902. doi:10.1016/j.pnpbp.2009.04.018.
21. Dennis, P. A., Ulmer, C. S., Calhoun, P. S., Sherwood, A., Watkins, L. L., Dennis, M. F., and Beckham, J. C. (2014). Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia. J. Psychosom. Res. 77, 45-50. doi:10.1016/j.jpsychores.2014.05.001.
22. Dzubur Kulenovic, A., Kucukalic, A., and Malec, D. (2008). Changes in plasma lipid concentrations and risk of coronary artery disease in army veterans suffering from chronic posttraumatic stress disorder. Croat. Med. J. 49, 506-14. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2525827&tool=pmcentrez&rendertype=abstract [Accessed January 3, 2015].
23. Edmondson, D., Davidson, K. W., and Cohen, B. E. (2013). Posttraumatic Stress Disorder and Cardiovascular Disease. Prog. Cardiovasc. Dis. 55, 548-556. Available at: http://www.sciencedirect.com/science/article/pii/S0033062013000613 [Accessed October 21, 2013].
24. Fleiss, J. (1986). Design and analysis of clinical experiments. First edit. Hoboken, NJ, USA: John Wiley & Sons, Inc. Available at: http://www.amazon.com/Design-Analysis-Clinical-Experiments-Joseph/dp/0471349917/ref=la_B001HMRNUU_1_1?s=books&ie=UTF8&qid=1418763697&sr=1-1 [Accessed December 16, 2014].
25. Garde, A. H., Hansen, A. M., Skovgaard, L. T., and Christensen, J. M. (2000). Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(1c), IgA, prolactin, and free testosterone in healthy women. Clin. Chem. 46, 551-9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10759480 [Accessed November 18, 2014].
26. Gill, J. M., Saligan, L., Woods, S., and Page, G. (2009). PTSD is associated with an excess of inflammatory immune activities. Perspect. Psychiatr. Care 45, 262-77. doi:10.1111/j.1744-6163.2009.00229.x.
27. Gill, J., Vythilingam, M., and Page, G. G. (2008). Low cortisol, high DHEA, and high levels of stimulated TNF-a, and IL-6 in women with PTSD. J. Trauma. Stress 21, 530-539. doi:10.1002/jts.20372.
28. Gola, H., Engler, H., So Mmershof, A., Adenauer, H., Kolassa, S., Schedlowski, M., Groettrup, M., Elbert, T., and Kolassa, I.-T. (2013). Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 13, 40. doi:10.1186/1471-244X-13-40.
29. Gonçalves, P., Ricardo, J., and Martel, F. (2015). Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms. Eur. Neuropsychopharmacol. 25, 1-16. doi:10.1016/j.euroneuro.2014.11.008.
30. Grossman, R., Yehuda, R., Boisoneau, D., Schmeidler, J., and Giller, E. L. (1996). Prolactin response to low-dose dexamethasone challenge in combat-exposed veterans with and without posttraumatic stress disorder and normal controls. Biol. Psychiatry 40, 1100-5. doi:10.1016/S0006-3223(95)00600-1.
31. Hadlow, N. C., Brown, S., Wardrop, R., and Henley, D. (2014). The effects of season, daylight saving and time of sunrise on serum cortisol in a large population. Chronobiol. Int. 31, 243-51. doi:10.3109/07420528.2013.844162.
32. Hauck, S., Kapczinski, F., Roesler, R., De Moura Silveira, é., Magalhães, P. V., Kruel, L. R. P., Schestatsky, S. S., and Ceitlin, L. H. F. (2010). Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Prog. Neuro-Psychopharmacology Biol. Psychiatry 34, 459-462. doi:10.1016/j.pnpbp.2010.01.010.
33. Hazeldine, J., Arlt, W., and Lord, J. M. (2010). Dehydroepiandrosterone as a regulator of immune cell function. J. Steroid Biochem. Mol. Biol. 120, 127-36. doi:10.1016/j.jsbmb.2009.12.016.
34. Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., and Simon, N. M. (2009). Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress. Anxiety 26, 447-455. doi:10.1002/da.20564.
35. Jendricko, T., Vidovic, A., Grubišic-Ilic, M., Romic, Ž., Kovacic, Z., Kozaric-Kovacic, D., and Grubišic-ilic, M. (2009). Homocysteine and serum lipids concentration in male war veterans with posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 134-40. doi:10.1016/j.pnpbp.2008.11.002.
36. Jergovic, M., Bendelja, K., Vidovic, Savic, A., Vojvoda, V., Aberle, N., Rabatic, S., Jovanovic, T., and Sabioncello, A. (2014a). Patients with posttraumatic stress disorder exhibit an altered phenotype of regulatory T cells. Allergy, Asthma Clin. Immunol. 10, 43. doi:10.1186/1710-1492-10-43.
37. Jergovic, M., Tomicevic, M., Vidovic, A., Bendelja, K., Savic, A., Vojvoda, V., Rac, D., Lovric-Cavar, D., Rabatic, S., Jovanovic, T., et al. (2014b). Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 54, 275-83. doi:10.1016/j.pnpbp.2014.06.010.
38. Kagan, B. L., Leskin, G., Haas, B., Wilkins, J., and Foy, D. (1999). Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol. Psychiatry 45, 374-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10023518 [Accessed January 3, 2015].
39. Von Känel, R., Abbas, C. C., Begré, S., Saner, H., Gander, M.-L., and Schmid, J.-P. (2010a). Posttraumatic stress disorder and soluble cellular adhesion molecules at rest and in response to a trauma-specific interview in patients after myocardial infarction. Psychiatry Res. 179, 312-317. Available at: http://www.sciencedirect.com/science/article/pii/S0165178109002133 [Accessed October 21, 2013].
40. Von Känel, R., Begré, S., Abbas, C. C., Saner, H., Gander, M.-L., Schmid, J.-P., and Känel, R. Von (2010b). Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation 17, 39-46. doi:10.1159/000243084.
41. Von Känel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., Schnyder, U., Esearch, R., and Ka, R. Von (2007). Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 41, 744-752. doi:10.1016/j.jpsychires.2006.06.009.
42. Von Känel, R., Hepp, U., Traber, R., Kraemer, B., Mica, L., Keel, M., Mausbach, B. T., Schnyder, U., and Känel, R. Von (2008). Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder. Psychiatry Res. 158, 363-373. doi:10.1016/j.psychres.2006.12.003.
43. Kanter, E. D., Wilkinson, C. W., Radant, A. D., Petrie, E. C., Dobie, D. J., McFall, M. E., Peskind, E. R., and Raskind, M. A. (2001). Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol. Psychiatry 50, 238-245. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11522257 [Accessed January 6, 2015].
44. Karlovic, D., Buljan, D., Martinac, M., and Marcinko, D. (2004a). Serum lipid concentrations in Croatian veterans with post-traumatic stress disorder, post-traumatic stress disorder comorbid with major depressive disorder, or major depressive disorder. J. Korean Med. Sci. 19, 431-6. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2816847&tool=pmcentrez&rendertype=abstract [Accessed January 3, 2015].
45. Karlovic, D., Martinac, M., Buljan, D., and Zoricic, Z. (2004b). Relationship between serum lipid concentrations and posttraumatic stress disorder symptoms in soldiers with combat experiences. Acta Med. Okayama 58, 23-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15157008 [Accessed January 3, 2015].
46. Katz, C., Stein, M., Richardson, J. D., Seedat, S., and Sareen, J. (2011). "A Review of Interventions for Treatment-Resistant Posttraumatic Stress Disorder," in Different Views of Anxiety Disorders, ed. S. Selek (InTech), 251-270. Available at: http://www.intechopen.com/books/different-views-of-anxiety-disorders/a-review-ofinterventions-for-treatmentresistant-posttraumatic-stress-disorder.
47. Keane, T. M., Street, A. E., and Stafford, J. (2004). "The assessment of military-related PTSD," in Assessing Psychological Trauma and PTSD, eds. J. P. Wilson and T. M. Keane (New York: The Guilford Press), 262-285.
48. Kellner, M., Muhtz, C., Peter, F., Dunker, S., Wiedemann, K., and Yassouridis, A. (2010). Increased DHEA and DHEA-S plasma levels in patients with post-traumatic stress disorder and a history of childhood abuse. J. Psychiatr. Res. 44, 215-9. doi:10.1016/j.jpsychires.2009.08.009.
49. King, L. A., King, D. W., Leskin, G., and Foy, D. W. (1995). The Los Angeles Symptom Checklist: A Self Report Measure of Posttraumatic Stress Disorder. Assessment 2, 1-17. doi:10.1177/1073191195002001001.
50. De Kloet, C. S., Vermetten, E., Geuze, E., Kavelaars, A., Heijnen, C. J., and Westenberg, H. G. M. (2006). Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J. Psychiatr. Res. 40, 550-67. doi:10.1016/j.jpsychires.2005.08.002.
51. Kozaric-Kovacic, D., Grubišic-Ilic, M., Romic, Ž., Vidovic, A., Jendricko, T., and Pivac, N. (2009). Body mass index in male Caucasian veterans with or without posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 1447-50. doi:10.1016/j.pnpbp.2009.07.026.
52. Laudenslager, M. L., Aasal, R., Adler, L., Berger, C. L., Montgomery, P. T., Sandberg, E., Wahlberg, L. J., Wilkins, R. T., Zweig, L., and Reite, M. L. (1998). Elevated cytotoxicity in combat veterans with long-term post-traumatic stress disorder: preliminary observations. Brain. Behav. Immun. 12, 74-9. doi:10.1006/brbi.1997.0513.
53. Laurent, H. K., Laurent, S. M., and Granger, D. A. (2013). Salivary nerve growth factor reactivity to acute psychosocial stress: a new frontier for stress research. Psychosom. Med. 75, 744-50. doi:10.1097/PSY.0b013e3182a85ffd.
54. Lehrner, A., and Yehuda, R. (2014). Biomarkers of PTSD: military applications and considerations. Eur. J. Psychotraumatol. 5. doi:10.3402/ejpt.v5.23797.
55. Levine, A. B., Levine, L. M., and Levine, T. B. (2014). Posttraumatic stress disorder and cardiometabolic disease. Cardiology 127, 1-19. doi:10.1159/000354.
56. Liao, S.-C., Lee, M.-B., Lee, Y.-J., and Huang, T.-S. (2004). Hyperleptinemia in subjects with persistent partial posttraumatic stress disorder after a major earthquake. Psychosom. Med. 66, 23-8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14747634 [Accessed January 4, 2015].
57. Lindqvist, D., Wolkowitz, O. M., Mellon, S., Yehuda, R., Flory, J. D., Henn-Haase, C., Bierer, L. M., Abu-Amara, D., Coy, M., Neylan, T. C., et al. (2014). Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain. Behav. Immun. 42, 81-8. doi:10.1016/j.bbi.2014.06.003.
58. Liu, X., Xie, X., Wang, K., and Cui, H. (2014). Efficacy and acceptability of atypical antipsychotics for the treatment of post-traumatic stress disorder: a meta-analysis of randomized, double-blind, placebo- controlled clinical trials. Psychiatry Res. 219, 543-9. doi:10.1016/j.psychres.2014.05.027.
59. Ljubotina, D., Pantic, Z., Franciskovic, T., Mladic, M., and Priebe, S. (2007). Treatment outcomes and perception of social acknowledgment in war veterans: follow-up study. Croat. Med. J. 48, 157-66. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2080524&tool=pmcentrez&r endertype=abstract [Accessed January 10, 2015].
60. Macfarlane, D. P., Forbes, S., and Walker, B. R. (2008). Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J. Endocrinol. 197, 189-204. doi:10.1677/JOE-08-0054.
61. Maia, D. B., Marmar, C. R., Mendlowicz, M. V, Metzler, T., Nóbrega, A., Peres, M. C., Coutinho, E. S., Volchan, E., and Figueira, I. (2008). Abnormal serum lipid profile in Brazilian police officers with post-traumatic stress disorder. J. Affect. Disord. 107, 259-63. doi:10.1016/j.jad.2007.08.013. Makin, H. L. J., and Gower, D. B. eds. (2010). Steroid Analysis. Dordrecht: Springer Netherlands doi:10.1023/b135931.
62. Makin, H. L. J., and Gower, D. B. eds. (2010). Steroid Analysis. Dordrecht: Springer Netherlands doi:10.1023/b135931
63. Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., and Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 30, 65-91. doi:10.1016/j.yfrne.2008.11.002.
64. Meewisse, M.-L., Reitsma, J. B., de Vries, G.-J., Gersons, B. P. R., and Olff, M. (2007). Cortisol and post-traumatic stress disorder in adults: systematic review and meta analysis. Br. J. Psychiatry 191, 387-92. doi:10.1192/bjp.bp.106.024877.
65. Miller, G. E., Chen, E., and Zhou, E. S. (2007). If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol. Bull. 133, 25-45. doi:10.1037/0033-2909.133.1.25.
66. Morris, M. C., Compas, B. E., and Garber, J. (2012). Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta analysis. Clin. Psychol. Rev. 32, 301-15. doi:10.1016/j.cpr.2012.02.002.
67. Mouthaan, J., Sijbrandij, M., Luitse, J. S. K., Goslings, J. C., Gersons, B. P. R., and Olff, M. (2014). The role of acute cortisol and DHEAS in predicting acute and chronic PTSD symptoms. Psychoneuroendocrinology 45, 179-86. doi:10.1016/j.psyneuen.2014.04.001.
68. O'Donovan, A., Cohen, B. E., Seal, K. H., Bertenthal, D., Margaretten, M., Nishimi, K., and Neylan, T. C. (2014). Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder. Biol. Psychiatry 77, 365-74. doi:10.1016/j.biopsych.2014.06.015.
69. Olff, M., Güzelcan, Y., de Vries, G.-J., Assies, J., and Gersons, B. P. R. (2006). HPA- and HPT-axis alterations in chronic posttraumatic stress disorder. Psychoneuroendocrinology 31, 1220-30. doi:10.1016/j.psyneuen.2006.09.003.
70. Orsillo, S. M. (2001). "Measures for acute stress disorder and posttraumatic stress disorder," in Practitioner's guide to empirically based measures of anxiety, eds. M. Antony and S. M. Orsillo (New York: KluwerAcademic/Plenum), 255-307.
71. Pico-Alfonso, M. A., Garcia-Linares, M. I., Celda-Navarro, N., Herbert, J., and Martinez, M. (2004). Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence. Biol. Psychiatry 56, 233-40. doi:10.1016/j.biopsych.2004.06.001.
72. Pivac, N., and Kozaric-Kovacic, D. (2006). Pharmacotherapy of treatment-resistant combat910 related posttraumatic stress disorder with psychotic features. Croat. Med. J. 47, 440-51. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2080433&tool=pmcentrez&r endertype=abstract [Accessed January 9, 2015].
73. Priebe, S., Bogic, M., Ajdukovic, D., Franciskovic, T., Galeazzi, G. M., Kucukalic, A., Lecic- Tosevski, D., Morina, N., Popovski, M., Wang, D., et al. (2010). Mental disorders following war in the Balkans: a study in 5 countries. Arch. Gen. Psychiatry 67, 518-28. doi:10.1001/archgenpsychiatry.2010.37.
74. Priebe, S., Matanov, A., Jankovic Gavrilovic, J., McCrone, P., Ljubotina, D., Knezevic, G., Kucukalic, A., Franciskovic, T., and Schützwohl, M. (2009). Consequences of untreated posttraumatic stress disorder following war in former Yugoslavia: morbidity, subjective quality of life, and care costs. Croat. Med. J. 50, 465-75. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2765735&tool=pmcentrez&r endertype=abstract [Accessed December 30, 2014].
75. Rasmusson, A. M., Vasek, J., Lipschitz, D. S., Vojvoda, D., Mustone, M. E., Shi, Q., Gudmundsen, G., Morgan, C. A., Wolfe, J., and Charney, D. S. (2004). An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacology 29, 1546-57. doi:10.1038/sj.npp.1300432.
76. Sabes-Figuera, R., McCrone, P., Bogic, M., Ajdukovic, D., Franciskovic, T., Colombini, N., Kucukalic, A., Lecic-Tosevski, D., Morina, N., Popovski, M., et al. (2012). Long-term impact of war on healthcare costs: An eight-country study. PLoS One 7, e29603. doi:10.1371/journal.pone.0029603.
77. Schmidt, U., Willmund, G.-D., Holsboer, F., Wotjak, C. T., Gallinat, J., Kowalski, J. T., and Zimmermann, P. (2015). Searching for non-genetic molecular and imaging PTSD risk and resilience markers: Systematic review of literature and design of the German Armed Forces PTSD biomarker study. Psychoneuroendocrinology 51, 444-58. doi:10.1016/j.psyneuen.2014.08.020.
78. Schweitzer, I., Morris, P., Hopwood, M., Maguire, K., and Norman, T. (2004). Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorder. Int. J. Neuropsychopharmacol. 7, 291-8. doi:10.1017/S1461145704004195.
79. Serrani Azcurra, D. (2010). E arly markers of endothelial dysfunction posttraumatic stress disorder. Role in atherogenesis. Rev. Psiquiatr. y salud Ment. 3, 128-36. doi:10.1016/j.rpsm.2010.09.004.
80. Solter, V., Thaller, V., Karlovic, D., and Crnkovic, D. (2002). Elevated serum lipids in veterans with combat-related chronic posttraumatic stress disorder. Croat. Med. J. 43, 685-9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12476477 [Accessed January 3, 2015].
81. Sommershof, A., Aichinger, H., Engler, H., Adenauer, H., Catani, C., Boneberg, E.-M., Elbert, T., Groettrup, M., and Kolassa, I.-T. (2009). Substantial reduction of naïve and regulatory T cells following traumatic stress. Brain. Behav. Immun. 23, 1117-24. doi:10.1016/j.bbi.2009.07.003.
82. Söndergaard, H. P., Hansson, L.-O., and Theorell, T. (2002). Elevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden. Psychother. Psychosom. 71, 298-303. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12207110 [Accessed December 29, 2014].
83. Song, Y., Zhou, D., Guan, Z., and Wang, X. (2007). Disturbance of serum interleukin-2 and interleukin-8 levels in posttraumatic and non-posttraumatic stress disorder earthquake survivors in northern China. Neuroimmunomodulation 14, 248-54. doi:10.1159/000112050.
84. Song, Y., Zhou, D., and Wang, X. (2008). Increased serum cortisol and growth hormone levels in earthquake survivors with PTSD or subclinical PTSD. Psychoneuroendocrinology 33, 1155-9. doi:10.1016/j.psyneuen.2008.05.005.
85. Spielberger, C. D., Gorsuch, R. L., and Lushene, R. E. (1970). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press. Spivak, B., Maayan, R., Kotler, M., Mester, R., Gil-Ad, I., Shtaif, B., and Weizman, A. (2000). Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol. Med. 30, 1227-31. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12027057 [Accessed December 29, 2014].
86. Spivak, B., Shohat, B., Mester, R., Avraham, S., Gil-Ad, I., Bleich, A., Valevski, A., and Weizman, A. (1997). Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol. Psychiatry 42, 345-8. doi:10.1016/S0006-3223(96)00375-7.
87. Stieg, M. R., Sievers, C., Farr, O., Stalla, G. K., and Mantzoros, C. S. (2015). Leptin: A hormone linking activation of neuroendocrine axes with neuropathology. Psychoneuroendocrinology 51C, 47-57. doi:10.1016/j.psyneuen.2014.09.004.
88. Suarez, A. L. P., López-Rincón, G., Martínez Neri, P. A., and Estrada-Chávez, C. (2015). Prolactin in inflammatory response. Adv. Exp. Med. Biol. 846, 243-64. doi:10.1007/978-3-319-12114-7_11.
89. Tochigi, M., Umekage, T., Otani, T., Kato, T., Iwanami, A., Asukai, N., Sasaki, T., and Kato, N. (2002). Serum cholesterol, uric acid and cholinesterase in victims of the Tokyo subway sarin poisoning: a relation with post-traumatic stress disorder. Neurosci. Res. 44, 267-72. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12413655 [Accessed January 6, 2015].
90. Tucker, P., Ruwe, W. D., Masters, B., Parker, D. E., Hossain, A., Trautman, R. P., and Wyatt, D. B. (2004). Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol. Psychiatry 56, 121-8. doi:10.1016/j.biopsych.2004.03.009.
91. Vermetten, E., Baker, D., and Yehuda, R. (2015). New findings from prospective studies. Psychoneuroendocrinology 51, 441-3. doi:10.1016/j.psyneuen.2014.11.017.
92. Vidovic, A., Gotovac, K., Vilibic, M., Sabioncello, A., Jovanovic, T., Rabatic, S., Folnegovic Šmalc, V., and Dekaris, D. (2011). Repeated Assessments of Endocrine- and Immune-Related Changes in Posttraumatic Stress Disorder. Neuroimmunomodulation 18, 199-211. doi:10.1159/000322869.
93. Voicu, V., Medvedovici, A., Ranetti, A. E., and Radulescu, F. S. (2013). Drug-induced hypo997 and hyperprolactinemia: mechanisms, clinical and therapeutic consequences. Expert Opin. Drug Metab. Toxicol. 9, 955-68. doi:10.1517/17425255.2013.791283.
94. Wentworth, B., Stein, M., and Redwine, L. (2013). Post-Traumatic Stress Disorder: A Fast Track to Premature Cardiovascular Disease? Cardiol. Rev. 21, 16-22. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22717656.
95. World Health Organisation (1992). ICD-10, International Statistical Classification of Diseases and Health Related Problems, 10th Revision. Geneva: World Health Organisation.
96. Yehuda, R., Bierer, L. M., Sarapas, C., Makotkine, I., Andrew, R., and Seckl, J. R. (2009). Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroendocrinology 34, 1304-13. doi:10.1016/j.psyneuen.2009.03.018.
97. Yehuda, R., Brand, S. R., Golier, J. a, and Yang, R.-K. (2006). Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatr. Scand. 114, 187-93. doi:10.1111/j.1600-0447.2006.00801.x.
98. Yehuda, Rachel; Giller, Earl L.; Boisoneau, D. (1992). Prolactin response to dexamethasone in PTSD. Biol. Psychiatry 31, 171-172. doi:10.1016/0006-3223(92)90609-4.
99. Zakynthinos, E., and Pappa, N. (2009). Inflammatory biomarkers in coronary artery disease. J. Cardiol. 53, 317-333. Available at: http://www.sciencedirect.com/science/article/pii/S0914508709000112 [Accessed October 22, 2013].
100. Zoladz, P. R., and Diamond, D. M. (2013). Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature. Neurosci. Biobehav. Rev. 37, 860-95. doi:10.1016/j.neubiorev.2013.03.024.